Routine executive appointment with no immediate impact on operations or financials. Monitor for any strategic shifts under new President; no need for trading action.
Price Chart
Executive Summary
ARS Pharmaceuticals appointed Donn Casale as President effective June 1, 2026, replacing CEO Richard Lowenthal who previously held the role. The appointment includes a base salary of $575,000, target bonus of 45%, and a $6M stock option vesting over four years.
Key Facts
- Donn Casale appointed President, effective June 1, 2026, succeeding Richard Lowenthal.
- Annual base salary of $575,000 and target bonus of 45% of base salary.
- Stock option grant valued at approximately $6,000,000 vesting over four years (25% after one year, then monthly).
- Casale previously served as Chief Commercial Officer at Dynavax Technologies (acquired by Sanofi in 2026).
Financial Impact
Compensation package total initial value approximately $6.6M in salary plus option grant; no material financial impact on company.
Risk Factors
- Potential integration risk if Casale's commercial experience does not translate to ARS's product stage.
- No material financial risk from this filing alone.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-220671 |
| Document: d10320d8k.htm | 0001193125-26-220671 |
| Document: 0001193125-26-220671-index-headers.html | 0001193125-26-220671 |
| Document: 0001193125-26-220671-index.html | 0001193125-26-220671 |
| Document: 0001193125-26-220671.txt | 0001193125-26-220671 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | 144 | $4.29 $4.18 | ▲ +2.56% | ▲ +3.09% | $4.03 (+6.06%) |
Sep 28, 2026 28d ago | Court Ruling | $4.40 $4.31 | ▼ −2.05% | ▼ −1.84% | $4.03 (−8.41%) |
Sep 16, 2026 5w ago | Court Ruling | $4.15 $4.11 | ▼ −0.96% | ▼ −0.84% | $4.03 (−2.89%) |
Aug 3, 2026 12w ago | Press Release | $5.46 $5.32 | ▼ −2.56% | ▼ −4.37% | $4.03 (−26.19%) |
Jul 17, 2026 14w ago | Court Ruling | $6.44 $6.36 | ▼ −1.24% | ▼ −2.08% | $4.03 (−37.42%) |
Jul 7, 2026 15w ago | 8-K | $8.10 $7.88 | ▼ −2.72% | ▼ −3.56% | $4.03 (−50.25%) |
Jun 12, 2026 19w ago | Insider Cluster | $9.81 $9.70 | ▼ −1.12% | ▼ −0.53% | $4.03 (−58.92%) |
May 15, 2026 23w ago | 8-K | $7.43 $7.30 | ▼ −1.68% | ▼ −1.62% | $4.03 (−45.72%) |
May 15, 2026 23w ago | Press Release | $7.43 $7.30 | ▲ +1.68% | ▲ +1.62% | $4.03 (+45.72%) |
May 13, 2026 23w ago | 8-K | $8.01 $7.94 | ▼ −0.87% | ▼ −1.65% | $4.03 (−49.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers